Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients

Introduction: Fibromyalgia (FM) is a chronic disorder characterized by widespread pain with an enormous symptom burden. Its treatment efficacy is limited. Its pathogenesis involves immune dysregulation, which includes interleukin-6 (IL-6) production. Methods: We herein reported a case series of FM p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kuo-Tung, Liao, Tsai-Ling, Chen, Yi-Hsing, Chen, Der-Yuan, Lai, Kou-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376766/
https://www.ncbi.nlm.nih.gov/pubmed/37509414
http://dx.doi.org/10.3390/biomedicines11071774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376766/
https://www.ncbi.nlm.nih.gov/pubmed/37509414
http://dx.doi.org/10.3390/biomedicines11071774

Ejemplares similares